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RESULTS

BACKGROUND
Table 1

• Anticoagulation with unfractionated heparin (UFH) helps to mitigate the risk of
further thrombosis in acute coronary syndromes.
• The American College of Cardiology Foundation/American Heart Association
(ACCF/AHA) guidelines suggest the use of a 50-100 units per kilogram intravenous
bolus prior to percutaneous coronary intervention (PCI) depending on intended use
of a glycoprotein IIb/IIIa (GIIB/3A) antagonist.1
Heparin dose WITHOUT GIIB/3A
receptor antagonist use
Heparin Dose WITH GIIB/3A
Receptor Antagonist use

Baseline Characteristic

70-100 units per kilogram IV
bolus
50-70 units per kilogram IV
bolus

Figure 1

• The 2021 American College of Cardiology (ACC), the American Heart Association
(AHA), and the Society for Cardiovascular Angiography and Interventions (SCAI)
Guideline for Coronary Artery Revascularization recommend targeting an activated
clotting time (ACT) of 250-300 seconds during PCI.2
• Parkview Health guidelines currently recommends a 70 unit/kg UFH bolus in a
patient with an acute coronary syndrome.
Initial bolus before with NO prior
anticoagulation

70-100 units per kilogram IV
bolus

Table 3

n=120

Actual body weight, mean ± SD,
kilograms
Adjusted body weight, mean ± SD,
kilograms
PCI in past 12 months, n (%)

79.39 ±14.34

Bleed in past 12 months, n (%)

0 (0)

Home anticoagulant use, n (%)

0 (0)

Prior aspirin use, n (%)

20 (16.6)

Prior clopidogrel use, n (%)

9 (7.5)

Approach, n (%)
Radial
Femoral
Other

61 (50.8)
58 (48.3)
1 (0.8)

94.49 ± 25.71

5 (4.1)

Figure 4

• The use of 10,000-unit UFH boluses is becoming increasingly common in the
emergency department (ED) at Parkview Health prior to cardiac catheterization. For
many patients, this set dosing exceeds guideline recommendations.

Excluded:
No PCI: 1
Continuous heparin
order: 74
No ACT: 84
No STEMI diagnosis: 67
Other : 8

n=277
(84%)

58%

16%

OBJECTIVES
• The purpose of this retrospective chart-review study is to evaluate the safety and
efficacy of a 10,000 unit unfractionated heparin bolus in the emergency department
prior to PCI.
• The primary objective was percentage of ACT values within goal range of 250-300
seconds.
• Secondary objectives included major bleeding rate, weight-based UFH bolus dose
in comparison to guideline recommended bolus dose, percentage of initial ACT
values within goal range, protamine use, and need for additional UFH boluses.

354 Screened

Total Additional Doses of UFH Per Patient
n=53Given
After 10,000 Unit UFH Bolus
(16%)

Figure 2

2%

3%

20%

Heparin Results
Initial dose units/kg, mean ± SD (AdjBW)
Initial dose units/kg, mean ± SD (TBW)
Number of additional doses mean ±SD
Total UFH dose, mean ± SD
% of all ACT readings in goal range
First ACT reading in goal range (% of total)
First ACT above goal range (%)
First ACT below goal range (%)

Figure 3

DISCUSSION
• Mean total units of UFH received was 14,805.79 units over an average of 1.2 doses,
with 84% of patients requiring an additional dose of heparin during PCI.
• There was one additional bleeding event that occurred outside the 24-hour
timeframe.
• The patient who experienced a bleeding event received 2 doses of UFH, totaling
18,000 units of UFH meaning the bleeding event cannot be attributed to the 10,000
unit bolus alone.
• The study relied on documentation in the patient chart during PCI. The study is
unable to account for ACT values that were not documented or variabilities in the
documentation of sheath insertion and removal, making the time frame of PCI
difficult to evaluate in some cases.
• Greater than 80% of patients evaluated in this study required additional boluses,
making evaluation of the impact of the 10,000-unit bolus alone difficult.
• There were 5 patients with supratherapeutic initial ACT readings, 1 of those patients
required an additional UFH doses of 5000 units during PCI.

120 Included

Table 2

Secondary Outcomes

N=120 (%)

Bleeding events, major

1 (0.83)

Blood product usage, 24 hours

1 (0.83)

Protamine use

0 (0)

n=120 (%)
130.30 units/kg ± 25.41
112.78 units/kg ± 28.64
1.2 ± 0.894
14,805.79 units ± 3745.76
20 (16.6%)
19 (15.8%)
5 (4.2%)
96 (80%)

1%

5

4

3

2

Figure 5
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CONCLUSION& FUTURE DIRECTIONS

58%

Average ACT Readings

• Based on these results 10,000 unit UFH boluses prior to PCI do not put patients at
an increased risk for bleeding events.
• These 10,000 unit boluses should still be used with caution based on the results of
our study. The highest mg/kg dose based on actual body weight was >200 mg/kg.
• The mean unit per kilogram dose in the study was 130. 3 units per kilogram. Based
on these results it would be appropriate to recommend a 10,000 unit UFH bolus for
patients with an adjusted body weight greater than 75 kilograms. Any patient with
an adjusted body weight less than 75 kilograms should receive guideline directed
weight-based dosing.

120

• This was a retrospective chart review study at Parkview Regional Medical Center ED
between January 1st, 2020 and August 31st, 2022.
• Patients were identified based on diagnosis of myocardial infarction, who received a
10,000 unit bolus of UFH in the ED, were at least 18 years old, and underwent PCI
with at least 1 ACT value recorded.
• Exclusion criteria included an elapsed time of greater than 6 hours between UFH
bolus administration and PCI, or initiation of a heparin IV infusion before PCI.
• ACT values collected during PCI were recorded.
• Administration of additional UFH boluses and reversal agents was recorded, as well
as administration of blood products during and up to 24 hours after PCI.
• Manual chart review was completed to determine major bleed rates based on
Thrombolysis in Myocardial Infarction (TIMI) criteria.
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